Showing 1 - 20 of 216 results
Australia’s Open Pool Australian Lightwater (OPAL) reactor is a state-of-the-art 20 megawatt multi-purpose reactor that uses low enriched uranium (LEU) fuel to achieve a range of activities to benefit human health, enable research to support a more sustainable environment and provide innovative solutions for industry.
Frequently asked questions about ANSTO for the community.
ANSTO's OPAL reactor is one of the world's most advanced and reliable research reactors today. To ensure we can continue operating OPAL safely and reliably and maximise utilisation, ANSTO must regularly carry out maintenance and upgrades.
Radiation can be described as energy or particles from a source that travel through space or other mediums. Light, heat, and wireless communications are all forms of radiation.
The OPAL research reactor's design and integrated safety features mean it is extremely safe; a fact confirmed by independent analysis.
Radioisotopes are widely used in medicine, industry, and scientific research. New applications for radioisotopes are constantly being developed.
ANSTO recently re-started the OPAL Reactor after a six-month shutdown for essential maintenance and the installation of an upgraded facility.
The Medium Energy- X-ray Absorption Spectroscopy beamlines will provide access to XANES and EXAFS data from a bending magnet source, optimised for cutting-edge applications in biological, agricultural and environmental science in an energy range that is not currently available at the Australia Synchrotron.
See details of previously published customer updates from our Health products team.
ANSTO's Chief Nuclear Officer shares insights on the safe management of Australia's nuclear waste.
ANSTO has been tracking and publishing data on fine particle pollution from key sites around Australia, and internationally, for more than 20 years.
ANSTO has agreed to participate in an Australian trial of a review of research infrastructure access proposals in which applicants remain anonymous to aid the removal of structural barriers to the career progression of Women in STEM.
ANSTO shared expertise on next-generation reactors and nuclear power with sustainable energy experts at the Australian Academy of Science symposium in May.
ANSTO has been granted a patent in Australia and a number of European countries for the separation, a key radioactive contaminant in critical minerals processing, actinium-227, from process liquors used in minerals extraction.
ANSTO has released the Independent Safety Review of Building 23 - Nuclear medicine production facility.
The Australian Government recently signed a landmark emissions reduction technology deal with Great Britain, which includes nuclear energy and clean hydrogen among the six key low emission technologies the two countries hope to advance.